Limited Liability Partnership registration number OC308417 (England and Wales)
TRANSCEND BLOODSTOCK LIMITED LIABILITY PARTNERSHIP
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023
PAGES FOR FILING WITH REGISTRAR
TRANSCEND BLOODSTOCK LIMITED LIABILITY PARTNERSHIP
BALANCE SHEET
AS AT
30 JUNE 2023
30 June 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
2,197,891
2,299,145
Current assets
1,265
1,059
Creditors: amounts falling due within one year
(2,268)
(2,820)
Net current liabilities
(1,003)
(1,761)
Total assets less current liabilities
2,196,888
2,297,384
Net assets attributable to members
2,196,888
2,297,384
Represented by:
Loans and other debts due to members
2,299,604
2,399,935
Members' other interests
(102,716)
(102,551)
2,196,888
2,297,384
Notes to the financial statements
1
Employees

The average number of persons, excluding members, employed by the partnership during the year was as follows:

2023
2022
Number
Number
Employees
-
0
-
0

The members of thetrue LLP have elected not to include a copy of the profit and loss account within the financial statements.

Transcend Bloodstock Limited Liability Partnership is a Limited Liability Partnership incorporated in England and Wales. The registered office is Nelson House, Fleming Business Centre, Burdon Terrace, Jesmond, Newcastle upon Tyne, NE2 3AE.

For the financial year ended 30 June 2023 the Limited Liability Partnership was entitled to exemption from audit under section 477 of the Companies Act 2006 (as applied by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) relating to small limited liability partnerships.

The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to limited liability partnerships) with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

TRANSCEND BLOODSTOCK LIMITED LIABILITY PARTNERSHIP
BALANCE SHEET (CONTINUED)
AS AT
30 JUNE 2023
30 June 2023
- 2 -
The financial statements were approved by the members and authorised for issue on 22 February 2024 and are signed on its behalf by:
Sir A W G Wylie
Designated member
Limited Liability Partnership registration number OC308417 (England and Wales)
2023-06-302022-07-01falseCCH SoftwareCCH Accounts Production 2023.300OC3084172022-07-012023-06-30OC3084172023-06-30OC3084172021-07-012022-06-30OC308417bus:PartnerLLP12022-07-012023-06-30OC308417bus:LimitedLiabilityPartnershipLLP2022-07-012023-06-30OC308417bus:SmallCompaniesRegimeForAccounts2022-07-012023-06-30OC308417bus:Micro-entities2022-07-012023-06-30OC308417bus:AuditExemptWithAccountantsReport2022-07-012023-06-30OC308417bus:FullAccounts2022-07-012023-06-30xbrli:purexbrli:shares